Hauge T, Franco-Lie I, Hetland G, Waage A, Drewes AM, Fagerhol MK(2025) LeLISA: A New Lectin-Based Immunoassay for Evaluation of Mucinous and Serous Content in Pancreatic Cystic Neoplasms Dig Dis Sci(in press) DOI 10.1007/s10620-025-09188-4, PubMed 40591230
Strande V, Hagen M, Lund C, Asak Ø, Bengtson MB, Boyar R, Detlie TE, Frigstad SO, Henriksen M, Holten KIA, Hovde Ø, Huppertz-Hauss G, Høie O, Johansen I, Medhus AW, Olsen BC, Opheim R, Perminow G, Ricanek P, Torp R, Valeur J, Vatn S, Aabrekk TB, Moum B, Høivik MLet al.(2025) Predicting severe inflammatory bowel disease: a risk matrix model based on the IBSEN III inception cohort Scand J Gastroenterol, 60(7), 716-727 DOI 10.1080/00365521.2025.2512591, PubMed 40483585
Hansen SH, Maseng MG, Grännö O, Vestergaard MV, Bang C, Olsen BC, Lund C, Olbjørn C, Løvlund EE, Vikskjold FB, Huppertz-Hauss G, Perminow G, Yassin H, Valeur J, Aass Holten KI, Henriksen M, Bengtson MB, Ricanek P, Opheim R, Boyar R, Torp R, Frigstad SO, Aabrekk TB, Detlie TE, Kristensen VAet al.(2025) Fecal Microbiome Reflects Disease State and Prognosis in Inflammatory Bowel Disease in an Adult Population-Based Inception Cohort Inflamm Bowel Dis(in press) DOI 10.1093/ibd/izaf060, PubMed 40285477